SCHEMBL10080438

SCHEMBL10080438

Cc1nc2c(s1)c(O)c(C(N)=O)c(=O)n2Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 2/20 0.41
FEN1 P39748 2/20 0.41
KCNH2 Q12809 1/20 0.41
P2RX3 P56373 1/20 0.41
BCL2 P10415 1/20 0.40
MCL1 Q07820 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
LMNA P02545 3/20 0.39
TSHR P16473 2/20 0.39
RAB9A P51151 2/20 0.39
PKM P14618 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 6/20 0.38
RECQL P46063 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2499880 0.84 EGLN1 (0.58) KCNH2EGLN1
SCHEMBL1522475 0.74 KDM4E (0.47) FEN1SMN1; SMN2LMNATSHRPKM
SCHEMBL1194498 0.72 KDM4E (0.57) MCL1SMN1; SMN2TSHRPKMALDH1A1
SCHEMBL1440727 0.70 EGLN1 (0.67) SMN1; SMN2LMNAALDH1A1RECQLKDM4E
SCHEMBL11422399 0.70 MEN1 (0.47) SMN1; SMN2LMNATSHRRAB9APKM
SCHEMBL11488105 0.69 CNR1 (0.47) ERCC5FEN1BCL2MCL1SMN1; SMN2
SCHEMBL1523169 0.69 KDM4E (0.54) KCNH2SMN1; SMN2LMNATSHRRAB9A
SCHEMBL1193842 0.67 KDM4E (0.50) SMN1; SMN2LMNATSHRALDH1A1KDM4E
SCHEMBL16099904 0.67 EGLN1 (0.47) ERCC5FEN1KDM4EMEN1KMT2A
SCHEMBL115127 0.66 PDE4B (0.38) SMN1; SMN2LMNATSHRCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2150251-B1 THIENOPYRIDINE AND THIAZOLOPYRIDINE DERIVATIVES THAT INHIBIT PROLYL HYDROXYLASE ACTIVITY AMGEN INC (US) 2012-06-27 EP disclosed